Mixed micelles self-assembled from block copolymers for drug delivery

被引:275
作者
Attia, Amalina Bte Ebrahim [1 ]
Ong, Zhan Yuin [1 ,2 ]
Hedrick, James L. [3 ,4 ]
Lee, Phin Peng [1 ]
Ee, Pui Lai Rachel [2 ]
Hammond, Paula T. [3 ,4 ]
Yang, Yi-Yan [1 ]
机构
[1] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore
[2] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
[3] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[4] MIT, Inst Soldier Nanotechnol, Cambridge, MA 02139 USA
关键词
Mixed micelles; Block copolymers; Drug delivery; Hydrophobic interactions; Stereocomplex; Hydrogen bonding; Ionic interactions; Chemical cross-linking; POLYION COMPLEX MICELLES; HYDROGEN-BONDING COMPLEXATION; POLYPEPTIDE GRAFT COPOLYMER; POLYMERIC MICELLES; DIBLOCK COPOLYMERS; MULTIDRUG-RESISTANCE; FOLATE-RECEPTOR; PATCHY NANOPARTICLES; CONTROLLED-RELEASE; ANTICANCER DRUGS;
D O I
10.1016/j.cocis.2010.10.003
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Mixed micelles self-assembled from two or more dissimilar block copolymers provide a direct and convenient approach to improve physical stability and enhance drug loading capacities of conventional polymeric micelles for drug delivery. The versatility of this approach also allows for the concomitant integration of multiple functionalities into a single system a feat that is synthetically challenging to accomplish with micelles formed from a single co-polymer. Through the careful selection and blending of structurally and/or functionally diverse block copolymers, a population of novel and multi-functional micelles bearing desirable attributes of each constituent copolymer can be easily fabricated without the need for elaborate synthetic schemes. As such, this review is focused on the various strategies used to form and stabilize mixed micelles for drug delivery and the methodologies employed to ascertain the establishment of mixed micelle formation. In vivo evidence demonstrating the effectiveness of mixed micelles will be presented. Lastly, future perspectives for the development of mixed micelle systems for drug delivery will also be discussed. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:182 / 194
页数:13
相关论文
共 117 条
[1]   Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials [J].
Alakhov, V ;
Klinski, E ;
Li, SM ;
Pietrzynski, G ;
Venne, A ;
Batrakova, E ;
Bronitch, T ;
Kabanov, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :113-134
[2]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[3]   Targeted delivery of nanoparticles for the treatment of lung diseases [J].
Azarmi, Shirzad ;
Roa, Wilson H. ;
Loebenberg, Raimar .
ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (08) :863-875
[4]   PLA stereocomplexes for controlled release of somatostatin analogue [J].
Bishara, A ;
Domb, AJ .
JOURNAL OF CONTROLLED RELEASE, 2005, 107 (03) :474-483
[5]   An isothermal titration calorimetry study of the interactions between an oxyphenylethylene/oxyethylene diblock copolymer and sodium dodecyl sulfate [J].
Castro, E ;
Taboada, P ;
Mosquera, C .
MOLECULAR PHYSICS, 2005, 103 (04) :579-585
[6]  
Chauba M., 2002, DRUG DELIVERY TECHNO, V2, P34
[7]   Strategies for constructing polymeric micelles and hollow spheres in solution via specific intermolecular interactions [J].
Chen, DY ;
Jiang, M .
ACCOUNTS OF CHEMICAL RESEARCH, 2005, 38 (06) :494-502
[8]   Enantiomeric PLA-PEG block copolymers and their stereocomplex micelles used as rifampin delivery [J].
Chen, Li ;
Xie, Zhigang ;
Hu, Junli ;
Chen, Xuesi ;
Jing, Xiabin .
JOURNAL OF NANOPARTICLE RESEARCH, 2007, 9 (05) :777-785
[9]   Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs [J].
Chiappetta, Diego A. ;
Sosnik, Alejandro .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (03) :303-317
[10]   Polymeric micelles for drug delivery [J].
Croy, S. R. ;
Kwon, G. S. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (36) :4669-4684